How to Perform a Urease Test: Principle, Procedure, and Interpretation

The urease test is a biochemical assay used to detect the presence of the enzyme urease in microorganisms, which catalyzes the hydrolysis of urea to ammonia and carbon dioxide. This test is particularly valuable for identifying Helicobacter pylori in clinical specimens, differentiating members of the Enterobacteriaceae family, and characterizing other urease-positive bacteria such as Proteus species, Klebsiella pneumoniae, and Staphylococcus saprophyticus. The test is performed using urea broth or urea agar, with a pH indicator (typically phenol red) that changes color from yellow to pink or magenta when ammonia is produced, indicating a positive result. The urease test is a cornerstone of clinical microbiology, food safety testing, and environmental monitoring due to its simplicity, rapidity, and diagnostic utility.

At a Glance

Scientific Principle

The urease test relies on the enzymatic hydrolysis of urea by urease (urea amidohydrolase, EC 3.5.1.5). Urease catalyzes the following reaction:

[ \text{CO(NH}_2\text{)}_2 + \text{H}_2\text{O} \xrightarrow{\text{urease}} 2\text{NH}_3 + \text{CO}_2 ]

The ammonia produced dissolves in water to form ammonium hydroxide (NH₄OH), which raises the pH of the medium. The test medium contains urea as the substrate and phenol red as a pH indicator. Phenol red is yellow at pH ≤ 6.8 and turns pink or magenta at pH ≥ 8.1. Therefore, a color change from yellow to pink indicates urease activity.

The rate of urease production varies among microorganisms. Some bacteria, such as Proteus species and H. pylori, produce urease rapidly (within minutes to hours), while others, like Klebsiella pneumoniae, may require 24–48 hours for detectable activity. This variation forms the basis for distinguishing between rapid urease-positive organisms and slow urease-positive organisms.

The urease test is particularly critical for diagnosing H. pylori infection. As noted in a 2024 study, H. pylori is "recognized globally as one of the most widespread bacteria, serves as primary etiological agent for numerous gastroduodenal diseases" [1]. The rapid urease test (RUT) performed on gastric biopsy specimens is a standard diagnostic method, with the same study reporting that "17 tested positive for H. pylori, which was in complete agreement with the results obtained from the rapid urease test" [1]. This demonstrates the high concordance between RUT and molecular methods.

Materials and Instrumentation Choices

Media Selection

Urea Broth (Christensen's Urea Broth)

• Composition: Urea (2%), peptone, glucose, monopotassium phosphate, phenol red, and sodium chloride
• Format: Sterile tubes (3–5 mL per tube)
• Advantages: Rapid results, easy to observe color change, suitable for large batch testing
• Disadvantages: Less stable than agar; must be used within 2–4 weeks of preparation

Urea Agar (Christensen's Urea Agar)

• Composition: Same as broth plus agar (1.5%)
• Format: Slants in screw-cap tubes
• Advantages: Longer shelf life (4–6 months), allows observation of colony morphology
• Disadvantages: Slower diffusion of ammonia; results may take longer

Rapid Urease Test (RUT) Kits

• Commercial kits (e.g., CLOtest, PyloriTek) designed specifically for H. pylori detection
• Format: Gel or membrane containing urea and pH indicator
• Advantages: Results within 1–2 hours; optimized for clinical biopsy specimens
• Disadvantages: Higher cost; limited to H. pylori detection

Inoculation Tools

• Sterile inoculating loops (10 µL loop for broth; 1 µL loop for agar)
• Sterile swabs (for biopsy specimens in RUT)
• Bunsen burner or biosafety cabinet for aseptic technique

Incubation Equipment

• Incubator set at 35–37°C (standard for most bacteria)
• For H. pylori: microaerophilic conditions (5% O₂, 10% CO₂, 85% N₂) may be required for primary isolation, but RUT can be performed aerobically

Quality Control Strains

• Positive control: Proteus mirabilis (ATCC 29906) or H. pylori (ATCC 43504)
• Negative control: Escherichia coli (ATCC 25922)

Storage and Stability

• Prepared urea media should be stored at 2–8°C in sealed containers to prevent ammonia absorption from the environment
• Do not use media that has changed color (pink) before inoculation
• Commercial RUT kits should be stored according to manufacturer instructions, typically at room temperature

Procedure

Preparation

1. Media preparation: If using commercial dehydrated media, follow manufacturer instructions for reconstitution. For Christensen's urea agar, autoclave the base medium (without urea) at 121°C for 15 minutes, cool to 50°C, then add filter-sterilized urea solution (20% w/v) to achieve a final concentration of 2%. Dispense into sterile tubes and slant for agar.

2. Quality control: Before testing unknown isolates, verify that positive and negative control strains produce expected results. Document QC results in the laboratory logbook.

3. Specimen preparation: For pure cultures, use an 18–24 hour culture grown on non-selective medium (e.g., tryptic soy agar or blood agar). For clinical specimens (gastric biopsies), follow the specific protocol for the RUT kit being used.

Inoculation

For Urea Broth:

1. Label the tube with the organism identification, date, and technician initials.
2. Using a sterile loop, pick 2–3 well-isolated colonies from the pure culture.
3. Emulsify the inoculum in the urea broth by gently rotating the loop against the tube wall.
4. Avoid vigorous shaking to prevent aeration, which can cause false-positive color changes.
5. Loosen the cap slightly to allow gas exchange.

For Urea Agar Slants:

1. Using a sterile loop, streak the inoculum across the entire slant surface.
2. Do not stab the butt, as urease activity is primarily aerobic.
3. Tighten the cap loosely to maintain moisture while allowing air exchange.

For Rapid Urease Test (Clinical Biopsy):

1. Place the biopsy specimen directly into the RUT well or gel.
2. Ensure the specimen is fully submerged or in contact with the reagent.
3. Seal the device according to manufacturer instructions.

Incubation

• Standard test: Incubate at 35–37°C aerobically for up to 24 hours.
• Rapid urease test: Incubate at 35–37°C and examine at 1, 2, and 4 hours.
• Slow urease test: If negative at 24 hours, re-incubate and examine at 48 hours.

Reading and Recording

• Examine tubes or slants against a white background under good lighting.
• Record the time of first observation of color change.
• Document the intensity of color change (weak positive = light pink; strong positive = deep magenta).
• For RUT kits, follow the manufacturer's color chart for interpretation.

Quality Checks

Internal Quality Control

External Quality Assessment

• Participate in proficiency testing programs (e.g., from CAP, UK NEQAS) at least annually.
• Document all QC failures and corrective actions.

Media Performance Checks

• Verify pH of prepared media (should be 6.8 ± 0.2).
• Check for contamination by incubating one uninoculated tube per batch.
• Discard any medium that shows color change or turbidity before use.

Result Interpretation

Positive Result

• Appearance: Pink to magenta color throughout the medium
• Timing:
  • Rapid positive: Color change within 1–6 hours (e.g., Proteus spp., H. pylori)
  • Slow positive: Color change after 24–48 hours (e.g., Klebsiella spp., Staphylococcus spp.)
• Interpretation: Organism produces urease

Negative Result

• Appearance: No color change; medium remains yellow or orange
• Timing: No change at 24 hours (extend to 48 hours for slow urease producers)
• Interpretation: Organism does not produce urease

Weak Positive Result

• Appearance: Light pink or orange-pink color
• Interpretation: Weak urease activity; may indicate a slow urease producer or low inoculum

False-Positive Results

• Pre-existing alkalinity of the medium (check pH before use)
• Contamination with ammonia from the environment (store media properly)
• Over-incubation leading to non-specific color change

False-Negative Results

• Insufficient inoculum
• Old or non-viable culture
• Incubation temperature too low
• Urea degradation in old media (urea hydrolyzes spontaneously over time)

Clinical Interpretation for H. pylori

The rapid urease test for H. pylori is considered positive if color change occurs within 2 hours. A 2025 study demonstrated that "the novel method combining endoscopy with immediate intraprocedural gastric juice analysis for the detection of H. pylori, followed by AST in case of a positive find" showed high diagnostic accuracy [3]. The RUT is often used in conjunction with histology and culture for definitive diagnosis.

Troubleshooting

Limitations

1. Specificity: The urease test is not definitive for species identification. Multiple genera produce urease, and results must be interpreted in conjunction with other biochemical tests (e.g., catalase, oxidase, indole).

2. Sensitivity for H. pylori: The rapid urease test has reported sensitivity of 85–95% for H. pylori detection. False negatives can occur with low bacterial load, recent antibiotic use, or proton pump inhibitor therapy. A 2026 study comparing urea breath tests noted that "discordant cases underwent endoscopic reference testing (rapid urease test and histology, with immunohistochemistry where required)" [4], highlighting the need for multiple diagnostic modalities.

3. Time dependency: Some organisms produce urease slowly, requiring extended incubation. Laboratories must establish clear protocols for reading times to avoid premature negative calls.

4. Medium stability: Urea is unstable in solution and hydrolyzes spontaneously over time. Prepared media must be used within specified timeframes and stored properly.

5. Inoculum effect: Heavy inoculum can produce false-positive results due to pre-formed enzymes or metabolic byproducts. Standardized inoculum size is critical.

6. pH interference: Highly buffered specimens or media can mask pH changes, leading to false-negative results.

7. Organism viability: The test requires viable, metabolically active organisms. Dead or stressed cells may not produce detectable urease.

Documentation

Laboratory Records

Maintain the following documentation for each urease test performed:

1. Test request form: Patient/sample identifier, requesting physician, date of collection
2. Media preparation log: Date prepared, lot number, expiration date, QC results
3. Test worksheet: Organism ID, inoculum source, incubation time and temperature, result at each reading interval
4. QC log: Control strains used, expected and observed results, date, technician initials
5. Result report: Final interpretation (positive/negative), time to positivity, any comments

Standard Operating Procedure (SOP)

Each laboratory should maintain a written SOP that includes:

• Purpose and scope
• Principle of the test
• Materials and equipment
• Step-by-step procedure
• Quality control protocols
• Result interpretation criteria
• Troubleshooting guide
• Biosafety considerations
• References

Regulatory Compliance

• Follow CLSI (Clinical and Laboratory Standards Institute) guidelines for biochemical testing
• Adhere to local laboratory accreditation requirements (e.g., ISO 15189)
• Document all deviations from SOP and corrective actions taken

Biosafety

Risk Assessment

The urease test is typically performed with BSL-1 or BSL-2 organisms. According to the CDC/NIH Biosafety in Microbiological and Biomedical Laboratories (BMBL), 6th Edition, risk assessment should consider the pathogenicity of the organism, route of transmission, and laboratory procedures [6].

BSL-1 Practices (for non-pathogenic strains)

• Standard microbiological practices
• Hand washing after handling cultures
• No eating, drinking, or applying cosmetics in the laboratory
• Decontaminate work surfaces daily and after spills

BSL-2 Practices (for clinical isolates or known pathogens)

• All BSL-1 practices plus:
• Restricted access to laboratory
• Use of biosafety cabinet for procedures that may generate aerosols
• Personal protective equipment (lab coat, gloves, eye protection)
• Autoclave all contaminated waste
• Sharps disposal in puncture-resistant containers

Specific Considerations for H. pylori

• H. pylori is classified as a BSL-2 organism
• Gastric biopsy specimens should be handled in a biosafety cabinet
• RUT kits should be sealed before disposal
• Positive cultures should be autoclaved before disposal

Decontamination

• All used media, tubes, and contaminated materials must be autoclaved at 121°C for 30 minutes before disposal
• Work surfaces should be disinfected with 10% bleach or 70% ethanol after each use
• Spills should be covered with absorbent material, flooded with disinfectant, and cleaned after appropriate contact time

Frequently Asked Questions

1. Can the urease test differentiate between H. pylori and other urease-positive bacteria?

No, the urease test alone cannot differentiate H. pylori from other urease-positive bacteria such as Proteus species or Klebsiella pneumoniae. H. pylori is distinguished by its rapid urease activity (positive within 1–2 hours), microaerophilic growth requirements, and characteristic morphology on Gram stain (curved or spiral rods). Definitive identification requires additional tests including oxidase (positive), catalase (positive), and molecular methods such as PCR or the HP-MCDA-LFB assay described in a 2024 study, which "achieved a perfect specificity rate of 100%, exhibiting no cross-reactivity with non-Helicobacter isolates" [1].

2. Why does the rapid urease test sometimes give false-negative results for H. pylori?

False-negative RUT results can occur due to several factors: low bacterial load in the biopsy specimen, recent use of antibiotics or proton pump inhibitors (which suppress H. pylori growth), sampling error (biopsy taken from non-infected area), or improper storage of the RUT kit. A 2025 study noted that "H. pylori antibiotic resistance is the most relevant cause of treatment failure" [3], and false negatives can lead to inappropriate treatment. To minimize false negatives, some protocols recommend taking multiple biopsies from different gastric sites and withholding proton pump inhibitors for at least two weeks before endoscopy.

3. How does the urease test compare with the urea breath test for diagnosing H. pylori?

Both tests detect urease activity, but they differ in methodology and application. The urease test (RUT) is performed on gastric biopsy specimens obtained during endoscopy and provides results within 1–2 hours. The urea breath test (UBT) is non-invasive, involves ingesting ¹³C-labeled urea, and measures ¹³CO₂ in breath samples. A 2026 randomized crossover trial found that "the 45 mg and 75 mg tests showed substantial agreement at 30 min (90.3%; κ = 0.766)" and that "the 45 mg protocol achieved excellent accuracy (AUC 0.953), statistically non-inferior to the 75 mg protocol (AUC 0.966; p = 0.50)" [4]. The UBT is preferred for non-invasive diagnosis and post-treatment confirmation, while RUT is used during endoscopy for immediate diagnosis.

4. Can the urease test be used for antibiotic susceptibility testing of H. pylori?

The standard urease test is not used for antibiotic susceptibility testing. However, the H. pylori urease test (HUT) can be used as a screening tool to identify positive specimens for subsequent susceptibility testing. A 2026 multicenter study described that "positive HUT samples were sent for susceptibility testing: they were checked for phenotypic/cultural resistance to amoxicillin, clarithromycin, metronidazole, levofloxacin, rifampicin and tetracycline and genotypic/molecular resistance to clarithromycin and fluoroquinolones" [2]. This approach allows targeted susceptibility testing only on confirmed H. pylori-positive specimens, improving laboratory efficiency.

References and Further Reading

1. Chen Y, Zhou J, Wang J, et al. Multiple cross displacement amplification-based lateral flow biosensor for rapid and sensitive detection of Helicobacter pylori. 2024. PubMed ID: 39611101. Link

2. Hildebrandt A, Wewers F, Uflacker L, et al. Routine Susceptibility Testing of Helicobacter pylori in Clinical Practice-Results of a Prospective Multicentre Study. 2026. PubMed ID: 42192648. Link

3. Vasapolli R, Ailloud F, Spießberger B, et al. Real-Time Assessment of H. pylori Infection to Guide Molecular Antibiotic Resistance Testing: A Combined Endoscopy-Gastric Juice Analysis Approach. 2025. PubMed ID: 39530235. Link

4. Huang J, Xie Y, Huang J, et al. Accuracy and Agreement of a 45 mg Versus a 75 mg ¹³C-Urea Breath Test for the Diagnosis of Helicobacter pylori Infection in Adults: A Randomized Crossover Trial. 2026. PubMed ID: 42196933. Link

5. Kedia R, Sivasankari S, Senthamarai S, et al. Prevalence of Anaerobic Bacteria in Surgical Site Infections in a Tertiary Care Hospital. 2026. PubMed ID: 42220803. Link

6. CDC and NIH. Biosafety in Microbiological and Biomedical Laboratories (BMBL), 6th Edition. U.S. Department of Health and Human Services, 2020. Link

7. National Institutes of Health. NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules. Link

8. National Center for Biotechnology Information. NCBI Bookshelf: Molecular Biology and Laboratory Methods. Link

Related Articles

• How to Perform a Catalase Test: Principle, Procedure, and Interpretation
• How to Perform an Oxidase Test: Principle, Procedure, and Interpretation
• How to Perform an Indole Test: Principle, Procedure, and Interpretation
• How to Perform a Coagulase Test: Slide and Tube Methods
• Pour Plate Method: Principle, Procedure, and Applications in Microbiology
• How to Perform a Kirby-Bauer Disk Diffusion Susceptibility Test: Protocol and Interpretation